Parexel talks global trial regulations at DIA 2011

By Gareth Macdonald

- Last updated on GMT

Related tags Contract research organisations Pharmacology

US CRO Parexel says the pharmaceutical industry’s desire to access international markets is the key challenge facing regulatory experts in the contract research sector.

Alberto Grignolo, VP of global strategy and services told that “twenty years ago the name of the game was running clinical trials in the US and Europe…nowadays companies begin drug development with the world in mind.”

Dr Grignolo explained that this means developers must interact with a greater number of regulatory bodies worldwide, which in turn is driving demand for contract research organisations (CRO) that can assist in this process.

“This creates opportunities to be creative,” he continued “clients want to take medicines to the world and they are looking for partners, such as Parexel, that can help them do this.​”

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more